296 related articles for article (PubMed ID: 33117115)
1. Rapidly (and Successfully) Translating Novel Brain Radiotracers From Animal Research Into Clinical Use.
Shaw RC; Tamagnan GD; Tavares AAS
Front Neurosci; 2020; 14():871. PubMed ID: 33117115
[TBL] [Abstract][Full Text] [Related]
2. A philosophy for CNS radiotracer design.
Van de Bittner GC; Ricq EL; Hooker JM
Acc Chem Res; 2014 Oct; 47(10):3127-34. PubMed ID: 25272291
[TBL] [Abstract][Full Text] [Related]
3. Efficiency gains in tracer identification for nuclear imaging: can in vivo LC-MS/MS evaluation of small molecules screen for successful PET tracers?
Joshi EM; Need A; Schaus J; Chen Z; Benesh D; Mitch C; Morton S; Raub TJ; Phebus L; Barth V
ACS Chem Neurosci; 2014 Dec; 5(12):1154-63. PubMed ID: 25247893
[TBL] [Abstract][Full Text] [Related]
4. Radiotracer development in psychiatry.
Pimlott SL
Nucl Med Commun; 2005 Mar; 26(3):183-8. PubMed ID: 15722898
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic-Derived Radiotracers for Positron Emission Tomography: Nuclear or "Unclear" Infection Imaging?
Gouws AC; Kruger HG; Gheysens O; Zeevaart JR; Govender T; Naicker T; Ebenhan T
Angew Chem Int Ed Engl; 2022 Nov; 61(45):e202204955. PubMed ID: 35834311
[TBL] [Abstract][Full Text] [Related]
6. Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination?
Huang Y; Zheng MQ; Gerdes JM
Curr Top Med Chem; 2010; 10(15):1499-526. PubMed ID: 20583995
[TBL] [Abstract][Full Text] [Related]
7. Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis.
Wuest M; Perreault A; Richter S; Knight JC; Wuest F
Apoptosis; 2019 Apr; 24(3-4):221-244. PubMed ID: 30684144
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro and in vivo evaluation of
Narayanaswami V; Tong J; Fiorino F; Severino B; Sparaco R; Magli E; Giordano F; Bloomfield PM; Prabhakaran J; Mann JJ; Vasdev N; Dahl K; Kumar JSD
EJNMMI Radiopharm Chem; 2020 May; 5(1):13. PubMed ID: 32430632
[TBL] [Abstract][Full Text] [Related]
9. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA
J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250
[TBL] [Abstract][Full Text] [Related]
10. Small Molecule PET Tracers for Transporter Imaging.
Kilbourn MR
Semin Nucl Med; 2017 Sep; 47(5):536-552. PubMed ID: 28826525
[TBL] [Abstract][Full Text] [Related]
11. Development of RGD-based radiotracers for tumor imaging and therapy: translating from bench to bedside.
Liu Z; Wang F
Curr Mol Med; 2013 Dec; 13(10):1487-505. PubMed ID: 24206140
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a PET/SPECT Radiopharmaceutical in Oncology.
Pisaneschi F; Viola NT
Mol Imaging Biol; 2022 Feb; 24(1):1-7. PubMed ID: 34542804
[TBL] [Abstract][Full Text] [Related]
13. Dual-radiotracer translational SPECT neuroimaging. Comparison of three methods for the simultaneous brain imaging of D
Tsartsalis S; Tournier BB; Habiby S; Ben Hamadi M; Barca C; Ginovart N; Millet P
Neuroimage; 2018 Aug; 176():528-540. PubMed ID: 29723640
[TBL] [Abstract][Full Text] [Related]
14. Developing Low Molecular Weight PET and SPECT Imaging Agents.
Xue L; Jie CVML; Desrayaud S; Auberson YP
ChemMedChem; 2024 Apr; ():e202400094. PubMed ID: 38634545
[TBL] [Abstract][Full Text] [Related]
15. Applications of in vivo imaging in the evaluation of the pathophysiology of viral and bacterial infections and in development of countermeasures to BSL3/4 pathogens.
Bocan TM; Panchal RG; Bavari S
Mol Imaging Biol; 2015 Feb; 17(1):4-17. PubMed ID: 25008802
[TBL] [Abstract][Full Text] [Related]
16. New
Fang W; Liu S
Curr Radiopharm; 2019; 12(3):171-186. PubMed ID: 30727939
[TBL] [Abstract][Full Text] [Related]
17. Role of Nuclear Imaging to Understand the Neural Substrates of Brain Disorders in Laboratory Animals: Current Status and Future Prospects.
D'Elia A; Schiavi S; Soluri A; Massari R; Soluri A; Trezza V
Front Behav Neurosci; 2020; 14():596509. PubMed ID: 33362486
[TBL] [Abstract][Full Text] [Related]
18. Preclinical dosimetry models and the prediction of clinical doses of novel positron emission tomography radiotracers.
Garrow AA; Andrews JPM; Gonzalez ZN; Corral CA; Portal C; Morgan TEF; Walton T; Wilson I; Newby DE; Lucatelli C; Tavares AAS
Sci Rep; 2020 Sep; 10(1):15985. PubMed ID: 32994530
[TBL] [Abstract][Full Text] [Related]
19. Predicting the success of a radiopharmaceutical for in vivo imaging of central nervous system neuroreceptor systems.
Wong DF; Pomper MG
Mol Imaging Biol; 2003; 5(6):350-62. PubMed ID: 14667490
[TBL] [Abstract][Full Text] [Related]
20. A Review of Molecular Imaging of Glutamate Receptors.
Kim JH; Marton J; Ametamey SM; Cumming P
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
